awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28481440-5C530C52-CA2D-4B16-8259-092B102697C0
Q28481440-5C530C52-CA2D-4B16-8259-092B102697C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28481440-5C530C52-CA2D-4B16-8259-092B102697C0
DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells
P2860
Q28481440-5C530C52-CA2D-4B16-8259-092B102697C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28481440-5C530C52-CA2D-4B16-8259-092B102697C0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a51556e4a544c5fff7a5434089cddc05b688341
P2860
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.